What is the evidence behind the use of red yeast rice for cholesterol lowering?

Sep 1, 2008 ... Treating elevated cholesterol, especially elevated low-density lipoprotein cholesterol (LDL-C), can slow and perhaps halt the progression of atherosclerosis. Conclusion: Patients with normal coronary angiogram were found to have normal non-HDL-C levels and those with coronary lesions had elevated non-HDL-C. The mean ... Dec 23, 2024 ... The non-HDL cholesterol to HDL cholesterol ratio is a newly developed metric that can assess the risk for atherosclerosis, chronic kidney ... Dec 22, 2022 ... High Apo B/low non-HDL-C was associated with a higher all-cause risk than low Apo B/high non-HDL-C. In conclusion, Johannesen, et al . [1] ... Oct 28, 2010 ... Non-HDL Cholesterol: A New Endpoint in Cardio-Metabolic Health Monitoring. To the Editor: Cardiovascular disease (CVD) is estimated to be ... Apr 13, 2022 ... Compared with placebo, rosuvastatin, given at moderate- and high-intensity doses, and simvastatin and atorvastatin at high-intensity doses, were ... Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol, ... May 30, 2024 ... Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence ... Jul 20, 2005 ... Non–HDL-C and the ratio of total cholesterol to HDL-C were as good as or better than apolipoprotein fractions in the prediction of future cardiovascular events. Aug 11, 2016 ... Objectives—. Non–high-density lipoprotein cholesterol (non-HDLC) levels reflect the full burden of cholesterol transported in atherogenic ...